Chesapeake Capital Corp’s Johnson & Johnson JNJ Stock Holding History

Chesapeake Capital Corp’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,208	Closed	-$520K	–	182
2024 Q3	$520K	Buy	+3,208	New	+$511K	0.47%	98

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Chesapeake Capital Corp's JNJ Position: Q4 2024 in Review

Chesapeake Capital Corp sold out of Johnson & Johnson (JNJ) in Q4 2024, closing a stake of 3,208 shares — an estimated $520K sold.

Chesapeake Capital Corp first reported a position in JNJ in Q3 2024 and held it in 1 quarter. The position peaked at $520K in Q3 2024. 4,105 funds tracked by Wall St. Rank hold JNJ as of Q4 2024.

Chesapeake Capital Corp reported no remaining Johnson & Johnson position as of Q4 2024 after selling out during the quarter.
Chesapeake Capital Corp sold 3,208 Johnson & Johnson shares in Q4 2024, an estimated $520K.
Chesapeake Capital Corp first reported a position in Johnson & Johnson in Q3 2024 and held it in 1 quarter.
Chesapeake Capital Corp's Johnson & Johnson position peaked at $520K in Q3 2024.
4,105 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2024.

Based on Chesapeake Capital Corp's 13F filing for Q4 2024, filed 11 Feb 2025.